CHEFARMA LIMITED

Company number 09622810 ·

Active

Net assets, total assets & total liabilities 2016 – 2025

  • Total assets
  • Net assets
  • Total liabilities
-£200k £0 £200k £400k £600k £800k 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total assets 2016: £312,763 Total assets 2017: £542,071 Total assets 2018: £648,729 Total assets 2019: £584,664 Total assets 2020: £603,231 Total assets 2021: £346,618 Total assets 2022: £268,580 Total assets 2023: £224,581 Total assets 2024: £190,859 Total assets 2025: £165,952 Total assets Net assets 2016: £279,089 Net assets 2017: £420,061 Net assets 2018: £537,883 Net assets 2019: £492,234 Net assets 2020: £505,145 Net assets 2021: £210,129 Net assets 2022: £175,479 Net assets 2023: £133,947 Net assets 2024: £96,961 Net assets 2025: £71,567 Net assets Total liabilities 2016: -£33,674 Total liabilities 2017: -£122,010 Total liabilities 2018: -£110,846 Total liabilities 2019: -£92,430 Total liabilities 2020: -£91,231 Total liabilities 2021: -£134,389 Total liabilities 2022: -£91,001 Total liabilities 2023: -£87,921 Total liabilities 2024: -£87,891 Total liabilities 2025: -£90,635 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2024 – 2025

0 0 0 0 1 1 1 1 2 2024 2025 2024: 2 2025: 2

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 10 years

Latest accounts (2025-06-30): Audit exempt.

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2025-06-30 £165,952 -£90,635 £71,567 2
2024-06-30 £190,859 -£87,891 £96,961 2
2023-06-30 £224,581 -£87,921 £133,947
2022-06-30 £268,580 -£91,001 £175,479
2021-06-30 £346,618 -£134,389 £210,129
2020-06-30 £603,231 -£91,231 £505,145
2019-06-30 £584,664 -£92,430 £492,234
2018-06-30 £648,729 -£110,846 £537,883
2017-06-30 £542,071 -£122,010 £420,061
2016-06-30 £312,763 -£33,674 £279,089

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.